Eisai Co.

From Wikipedia, the free encyclopedia

You have new messages (last change).

Eisai Co., Ltd. (エーザイ株式会社, Ēzai Kabushiki-gaisha^?) (TYO: 4523 ) is one of the global-leading pharmaceutical companies, ranking among the top 25. Headquartered in Tokyo, Japan, has some 9000 employees, among them about 1500 in research. Two of the key molecules Eisai developed are donepezil (Aricept) and rabeprazole (Aciphex).

[edit] External links

(English) Eisai Co., Ltd.

This article about a Japanese corporation- or company-related topic is a stub. You can help Wikipedia by expanding it.

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.

Retrieved from "http://en.wikipedia.org../../../e/i/s/Eisai_Co._8f71.html"

Categories: Companies listed on the Tokyo Stock Exchange | Japanese company stubs | Medical company stubs | Pharmaceutical companies of Japan

Views

Search

In other languages